The median OS was statistically significantly longer for nab-paclitaxel plus gemcitabine vs gemcitabine alone ( @ vs @ months , hazard ratio -LSB- HR -RSB- = @ , @ % confidence interval -LSB- CI -RSB- = @ to @ , P < @ ) .